4CHO SY, FOX E, MCCULLY C, et al. Plasma and cerebrospi- nal fluid pharmacokinetics of intravenously administered ABT-751 in non-human primates [ J ]. Cancer Chemother Pharmacol, 2007, 60(4) : 563 -567.
5CHANG JY, HSIEH HP, CHANG CY, et al. 7-Aroyl-aminoindoline-1-sulfonamides as a novel class of potent antitubulin agents [J]. J Med Chem, 2006, 49(23): 6656-6659.
6HU LX, LI ZR, LI Y, et al. Synthesis and structure-activity relationships of carbazole sulfonamides as a novel class of antimitotic agents against solid tumors[ J]. J Med Chem, 2006, 49(21 ) : 6273 - 6282.
7HU LX, LI ZR, WANG YM, et al. Novel pyridinyl and pyrimidinylcarbazole sulfonamides as antiproliferative agents [ J ]. Bioorg Med Chem Lett, 2007, 17(5) : 1193 -1196.
8KAMAL A, KHAN MNA, REDDY KS, et al. Synthesis of a new class of 2-anilino substituted nicotinyl arylsulfonylhydrazides as potential anticancer and antibacterial agents [ J ]. Bioorg Med Chem, 2007, 15(2): 1004-1013.
9TALBOT DC, VON PAWEL J, CATTELL E,et al. A randomized phase Ⅱ pharmacokinetic and pharmacodynamic study of indisulamas second-line therapy in patients with advanced nonsmall cell lung cancer[ J]. Clin Cancer Res, 2007, 13 (6) : 1816 - 1822.
10OWA T, YOSHINO H, OKAUCHI T, et al. Synthesis and biological evaluation of N-(7-indolyl) -3-pyridinesulfonamide derivatives as potent antitumor agents [ J ]. Bioorg Med Chem Lett, 2002, 12(16) : 2097 -2100.
5HOLSHOUSER M H, LOEFFLER L J, HALL I H. Effects of 3 - ehloromethylthiochromone - 1,1 - dioxide on nucleic acid, protein, and aerobic and anaerobic metabolism of ehrlich ascites tumor cells[-J~. Wiley online library Chemistry Views J Pharm Sci, 2006, 71(8):857- 861.
6DAS B, CHOWDHURY N, DAMODARK. A mild and efficient stereoselective synthesis of (Z)-and (E)-allyl sulfides and potent antifungal agent, (Z)- 3 -(4 - methoxybenzylidene)thiochroman - 4 - one from morita-haylis-hillman acetates [J].Chem Pharm Bull, 2007, 55(8):1274-1276.
7LIU Tianlin,XlE J ianhua, YU Shengliang. Studies on the synthesis and bioactivities of substituted dihydropyrazole de- rivatives[-J~. Acta Scientiarum Naturalium University Nankaiensis, 1999, 32(1):101 -104.
8PUIG-BASAGOITI F, TILGNER M, FORSHEY B M, et al. Triaryl pyrazoline compound inhibits flavivirus RNA rep- lication[J]. Antimicrob Agents Chemother, 2006, 50(4) :1320 - 1329.
9FARAG S S, VANDEUSEN J B, FEHNIGER T A. Biology and clinical impact of human natural killer cells[J].Int J Hematol, 2003, 78(1) :7- 17.
10MAK L,LIGGI S,TAN L,et al.Anti-cancer drug development:computational strategies to identify and target proteins involved in cancer metabolism [J].Curr Pharm Des,2013,19(4):532-577.
